How much revenue does DexCom (DXCM) generate?

DexCom (DXCM) generated $4.66B in total revenue for TTM through Q4 2025 with a net profit margin of 17.9%.

What is DexCom (DXCM) gross profit margin?

DexCom (DXCM) reported a gross profit margin of 60.1% for TTM through Q4 2025, equivalent to $2.80B in gross profit. This means DexCom retains 60.1% of each revenue unit after direct costs of production.

What is DexCom (DXCM) operating profit margin?

DexCom (DXCM) reported an operating profit margin of 19.6% for TTM through Q4 2025, equivalent to $911.80M in operating profit. This reflects profitability after operating expenses such as R&D, sales, and administration, but before taxes and non-operating items.

What is DexCom (DXCM) net profit margin?

DexCom (DXCM) reported a net profit margin of 17.9% for TTM through Q4 2025, equivalent to $836.30M in net profit. This is the share of revenue that remains as profit after all expenses, taxes, and non-operating items.

How much does DexCom (DXCM) invest in R&D?

DexCom (DXCM) invested $599.10M in research and development in TTM through Q4 2025 (12.9% of total revenue). R&D spending reflects investment in future products, services, and technologies.

How much does DexCom (DXCM) spend on capital expenditures?

DexCom (DXCM) spent $363.50M on capital expenditures in TTM through Q4 2025 (7.8% of total revenue). Capital expenditures represent investments in physical assets such as property, equipment, and infrastructure.

What is DexCom (DXCM) free cash flow?

DexCom (DXCM) generated $1.08B in free cash flow for TTM through Q4 2025 (23.1% of total revenue). Free cash flow is the cash remaining after capital expenditures and represents the company's ability to fund growth, pay dividends, or reduce debt.

What is DexCom (DXCM) effective tax rate?

DexCom (DXCM) had an effective tax rate of 23.2% for TTM through Q4 2025. This is the actual percentage of pre-tax income paid as income taxes.

How DexCom (DXCM) Makes Money: A Visual Guide

DexCom (DXCM) generated $4.66B in revenue, earning $836.30M in net profit (17.9% margin). Below is an interactive breakdown of how revenue flows through the income statement.

DexCom (DXCM) Income Statement Flow — TTM through Q4 2025

Calculated from the four most recent reported quarters, ending December 31, 2025 (reported February 12, 2026).

Frequently asked questions

How much revenue does DexCom (DXCM) generate?: DexCom (DXCM) generated $4.66B in total revenue for TTM through Q4 2025 with a net profit margin of 17.9%.
What is DexCom (DXCM) gross profit margin?: DexCom (DXCM) reported a gross profit margin of 60.1% for TTM through Q4 2025, equivalent to $2.80B in gross profit. This means DexCom retains 60.1% of each revenue unit after direct costs of production.
What is DexCom (DXCM) operating profit margin?: DexCom (DXCM) reported an operating profit margin of 19.6% for TTM through Q4 2025, equivalent to $911.80M in operating profit. This reflects profitability after operating expenses such as R&D, sales, and administration, but before taxes and non-operating items.
What is DexCom (DXCM) net profit margin?: DexCom (DXCM) reported a net profit margin of 17.9% for TTM through Q4 2025, equivalent to $836.30M in net profit. This is the share of revenue that remains as profit after all expenses, taxes, and non-operating items.
How much does DexCom (DXCM) invest in R&D?: DexCom (DXCM) invested $599.10M in research and development in TTM through Q4 2025 (12.9% of total revenue). R&D spending reflects investment in future products, services, and technologies.
How much does DexCom (DXCM) spend on capital expenditures?: DexCom (DXCM) spent $363.50M on capital expenditures in TTM through Q4 2025 (7.8% of total revenue). Capital expenditures represent investments in physical assets such as property, equipment, and infrastructure.
What is DexCom (DXCM) free cash flow?: DexCom (DXCM) generated $1.08B in free cash flow for TTM through Q4 2025 (23.1% of total revenue). Free cash flow is the cash remaining after capital expenditures and represents the company's ability to fund growth, pay dividends, or reduce debt.
What is DexCom (DXCM) effective tax rate?: DexCom (DXCM) had an effective tax rate of 23.2% for TTM through Q4 2025. This is the actual percentage of pre-tax income paid as income taxes.

Data & methodology

What is a Sankey diagram?: A Sankey diagram shows how money flows through a company from revenue to net profit. The width of each flow represents its proportion.
How is the data calculated?: We use the income statement from company filings. For TTM (Trailing Twelve Months), we use a pre-aggregated twelve-month view aligned with our latest four quarterly periods. Revenue flows to cost of revenue and gross profit, then to operating expenses (R&D, S&M, G&A) and operating profit.
When was this data last updated?: Based on company filings through TTM through Q4 2025.